Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FVBF3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,196
Award facts
- Contract value 100% obligated
- $25,195.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,195.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2ml injectable medication on June 3, 2025, with completion scheduled for June 4, 2025. This is a non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a broad portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Cosentyx, a specialty biologic medication used to treat autoimmune conditions, demonstrates the company's role in providing specialized pharmaceuticals for military medical needs. The contract was awarded through open competition, consistent with AmerisourceBergen's track record of winning competitively awarded contracts across DLA's medical supply chain for diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FVBF3?
SPE2DB25FVBF3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 3, 2025.
How much is contract SPE2DB25FVBF3 worth?
The government has obligated $25,196 on SPE2DB25FVBF3.
Is contract SPE2DB25FVBF3 an order under another contract?
Yes. SPE2DB25FVBF3 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVBF3 competed?
The extent of competition for SPE2DB25FVBF3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award